Voyager Therapeutics Inc (VYGR)
7.04
+1.05
(+17.53%)
USD |
NASDAQ |
Oct 04, 16:00
7.05
+0.01
(+0.14%)
After-Hours: 20:00
Voyager Therapeutics Shareholders Equity (Annual): 236.32M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 236.32M |
| December 31, 2022 | 59.02M |
| December 31, 2021 | 95.06M |
| December 31, 2020 | 154.32M |
| December 31, 2019 | 99.51M |
| December 31, 2018 | 46.45M |
| Date | Value |
|---|---|
| December 31, 2017 | 134.05M |
| December 31, 2016 | 135.92M |
| December 31, 2015 | 169.07M |
| December 31, 2014 | 1.149M |
| December 31, 2013 | -3.833M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
59.02M
Minimum
2022
236.32M
Maximum
2023
128.85M
Average
99.51M
Median
2019
Shareholders Equity (Annual) Benchmarks
| Biogen Inc | 14.80B |
| PTC Therapeutics Inc | -818.56M |
| Design Therapeutics Inc | 277.69M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |